Monitoring breast cancer response to neoadjuvant chemotherapy with ultrasound signal statistics and integrated backscatter.
<h4>Background</h4>Neoadjuvant chemotherapy (NAC) is used in patients with breast cancer to reduce tumor focus, metastatic risk, and patient mortality. Monitoring NAC effects is necessary to capture resistant patients and stop or change treatment. The existing methods for evaluating NAC...
Main Authors: | Hanna Piotrzkowska-Wróblewska, Katarzyna Dobruch-Sobczak, Ziemowit Klimonda, Piotr Karwat, Katarzyna Roszkowska-Purska, Magdalena Gumowska, Jerzy Litniewski |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0213749 |
Similar Items
-
Quantitative Assessment of the Echogenicity of a Breast Tumor Predicts the Response to Neoadjuvant Chemotherapy
by: Katarzyna Sylwia Dobruch-Sobczak, et al.
Published: (2021-07-01) -
Monitoring the response to neoadjuvant chemotherapy in patients with breast cancer using ultrasound scattering coefficient: A preliminary report
by: Katarzyna Dobruch-Sobczak, et al.
Published: (2019-06-01) -
Quantitative ultrasonography as a tool for the evaluation of breast tumor response to neoadjuvant chemotherapy
by: Piotrzkowska-Wróblewska Hanna, et al.
Published: (2022-04-01) -
Explaining a deep learning based breast ultrasound image classifier with saliency maps
by: Byra Michał, et al.
Published: (2022-04-01) -
Multiparametric ultrasound examination for response assessment in breast cancer patients undergoing neoadjuvant therapy
by: K. Dobruch-Sobczak, et al.
Published: (2021-01-01)